Effects of gestational low dose perfluorooctanoic acid on maternal and "anxiety-like" behavior in dams.
Ontology highlight
ABSTRACT: Pregnancy is a unique critical window with nearly ubiquitous exposure to low concentrations of endocrine disrupting chemicals, such as per- and poly-fluoroalkyl substances (PFAS). Human and animal research suggests that PFAS compounds disrupt hypothalamic-pituitary-adrenal axis function, with some evidence of altered "anxiety-like" behavior, but little is known about the potential effects on maternal mental health following exposures during pregnancy. Evaluating the consequences of gestational PFAS exposures on maternal health is essential, because approximately 1 in 10 women experience postpartum depression, often with increased anxiety. To address this gap, dams were exposed to a low dose, 0.1 mg/kg, of perfluorooctanoic acid (PFOA) from gestational day 0 to birth. Maternal behavior was
SUBMITTER: Merrill AK
PROVIDER: S-EPMC9464925 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA